CHRSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Coherus Oncology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$0.96−0.03 (-3.16%)
Close on Oct 19, 2026
- Market cap
- $148.42M
- P/E (TTM)
- 0.7
- Dividend yield
- –
SEC filings
40 of Coherus Oncology's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 28, 2026 | Aug 28, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 17, 2026 | Aug 17, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 17, 2026 | Aug 17, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2026 | Jun 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 27, 2026 | Jun 1, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 11, 2026 | May 11, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 27, 2026 | Apr 20, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 9, 2026 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 12, 2026 | Feb 17, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 4, 2026 | Feb 4, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 23, 2026 | Jan 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2026 | Jan 13, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 5, 2025 | Sep 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jul 3, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2025 | Jun 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 29, 2025 | May 30, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 11, 2025 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 22, 2025 | Apr 25, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 16, 2025 | Apr 22, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 11, 2025 | Apr 14, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2025 | Apr 1, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 17, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2025 | Mar 13, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2025 | Mar 10, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 4, 2025 | Mar 4, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 27, 2024 | Dec 4, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 2, 2024 | Dec 3, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 6, 2024 | SEC EDGAR |